Conditions

I recently saw a patient for a diabetes follow-up and had just gotten her lab values faxed over. Her A1c came back at 9.6, despite the patient telling me that her glucose meter readings were much lower. She even showed me the meter, and upon doing some averaging, it appeared that her A1c should be a lot lower....

Young children with type 1 diabetes often experience greater insulin variability, leading to more complications and a subpar quality of life.

The growing brain is more susceptible to adverse effects from glucose variability.

Earlier diagnosis and treatment prevent complications.

A recently published meta-analysis puts metformin to the test to see how well it lines up against other T2DM “Medication All-Star Team” members. 

The unique benefits of using empagliflozin need to be considered when determining treatments for type 2 patients.

A new phase 3 study on novel SGLT inhibitor shows favorable results in those living with severe renal impairment.

Adequate amounts of magnesium in the diet could reduce the risk of type 2 and cerebral vascular incidents. 

Do patients with prediabetes share the same vascular complication risk seen in patients with T2D?

A recent exploratory analysis of the REWIND trial evaluated a potential additive benefit to using a once-weekly GLP-1 RA.